Amber Implants Appoints Vincent Gardès to Lead VCFix® Spinal System Launch Amber Implants has appointed Vincent Gardès as CEO to spearhead the U.S. launch of the VCFix® spinal system, marking a pivotal shift toward commercialization.

Amber Implants Appoints Vincent Gardès to Lead VCFix® Spinal System Launch #Netherlands #The_Hague #Amber_Implants #VCFix_Spinal_System #Vincent_Gardès

Amber Implants' VCFix® Spinal System Receives FDA 510(k) Clearance, Revolutionizing Treatment for Spine Fractures Amber Implants has received FDA clearance for its VCFix® Spinal System, a breakthrough solution for vertebral compression fractures, aiming for commercial launch in 2026.

Amber Implants' VCFix® Spinal System Receives FDA 510(k) Clearance, Revolutionizing Treatment for Spine Fractures #United_States #The_Hague #Amber_Implants #VCFix #spinal_system

Amber Implants Releases Promising One-Year Results From VCFix® Clinical Trial for Spinal Injuries Amber Implants has announced significant one-year follow-up data from its VCFix® spinal system clinical trial, showcasing substantial safety and efficacy improvements.

Amber Implants Releases Promising One-Year Results From VCFix® Clinical Trial for Spinal Injuries #Netherlands #Spine_Health #The_Hague #Amber_Implants #VCFix